Design and Characterization of a DNA Vaccine Based on Spike with Consensus Nucleotide Sequence against Infectious Bronchitis Virus
- PMID: 33466810
- PMCID: PMC7830736
- DOI: 10.3390/vaccines9010050
Design and Characterization of a DNA Vaccine Based on Spike with Consensus Nucleotide Sequence against Infectious Bronchitis Virus
Abstract
Avian coronavirus infectious bronchitis virus (IBV) causes severe economic losses in the poultry industry, but its control is hampered by the continuous emergence of new genotypes and the lack of cross-protection among different IBV genotypes. We designed a new immunogen based on a spike with the consensus nucleotide sequence (S_con) that may overcome the extraordinary genetic diversity of IBV. S_con was cloned into a pVAX1 vector to form a new IBV DNA vaccine, pV-S_con. pV-S_con could be correctly expressed in HD11 cells with corresponding post-translational modification, and induced a neutralizing antibody response to the Vero-cell-adapted IBV strain Beaudette (p65) in mice. To further evaluate its immunogenicity, specific-pathogen-free (SPF) chickens were immunized with the pV-S_con plasmid and compared with the control pVAX1 vector and the H120 vaccine. Detection of IBV-specific antibodies and cell cytokines (IL-4 and IFN-γ) indicated that vaccination with pV-S_con efficiently induced both humoral and cellular immune responses. After challenge with the heterologous strain M41, virus shedding and virus loading in tissues was significantly reduced both by pV-S_con and its homologous vaccine H120. Thus, pV-S_con is a promising vaccine candidate for IBV, and the consensus approach is an appealing method for vaccine design in viruses with high variability.
Keywords: DNA vaccine; consensus nucleotide sequence; heterologous challenge; infectious bronchitis virus; spike ectodomain.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
The spike protein of the apathogenic Beaudette strain of avian coronavirus can elicit a protective immune response against a virulent M41 challenge.PLoS One. 2024 Jan 24;19(1):e0297516. doi: 10.1371/journal.pone.0297516. eCollection 2024. PLoS One. 2024. PMID: 38265985 Free PMC article.
-
Development and characterization of a recombinant infectious bronchitis virus expressing the ectodomain region of S1 gene of H120 strain.Appl Microbiol Biotechnol. 2014 Feb;98(4):1727-35. doi: 10.1007/s00253-013-5352-5. Epub 2013 Nov 28. Appl Microbiol Biotechnol. 2014. PMID: 24287931
-
[Rescue of the recombinant infectious bronchitis virus with the ectodomain region of H120 spike glycoprotein].Bing Du Xue Bao. 2014 Nov;30(6):668-74. Bing Du Xue Bao. 2014. PMID: 25868282 Chinese.
-
Combination of H120 and 1/96 avian infectious bronchitis virus vaccine strains protect chickens against challenge with IS/1494/06 (variant 2)-like infectious bronchitis virus.Acta Virol. 2017;61(2):150-160. doi: 10.4149/av_2017_02_04. Acta Virol. 2017. PMID: 28523921 Clinical Trial.
-
Avian infectious bronchitis virus.Rev Sci Tech. 2000 Aug;19(2):493-508. doi: 10.20506/rst.19.2.1228. Rev Sci Tech. 2000. PMID: 10935276 Review.
Cited by
-
Pathogenicity and molecular characterization of a GI-19 infectious bronchitis virus isolated from East China.Front Vet Sci. 2024 Aug 7;11:1431172. doi: 10.3389/fvets.2024.1431172. eCollection 2024. Front Vet Sci. 2024. PMID: 39170640 Free PMC article.
-
Salmonella typhimurium Vaccine Candidate Delivering Infectious Bronchitis Virus S1 Protein to Induce Protection.Biomolecules. 2024 Jan 20;14(1):133. doi: 10.3390/biom14010133. Biomolecules. 2024. PMID: 38275762 Free PMC article.
-
Lipid nanoparticles-mRNA based on the consensus sequences of avian coronavirus S1 and N genes protect animals against multiple viral infections.J Nanobiotechnology. 2025 Aug 30;23(1):595. doi: 10.1186/s12951-025-03668-5. J Nanobiotechnology. 2025. PMID: 40883775 Free PMC article.
-
Infectious Bronchitis Virus (Gammacoronavirus) in Poultry Farming: Vaccination, Immune Response and Measures for Mitigation.Vet Sci. 2021 Nov 12;8(11):273. doi: 10.3390/vetsci8110273. Vet Sci. 2021. PMID: 34822646 Free PMC article. Review.
-
Trans amplifying mRNA vaccine expressing consensus spike elicits broad neutralization of SARS CoV 2 variants.NPJ Vaccines. 2025 Jun 3;10(1):110. doi: 10.1038/s41541-025-01166-1. NPJ Vaccines. 2025. PMID: 40461576 Free PMC article.
References
-
- Ellis S., Keep S.P., Britton P., De Wit S., Bickerton E., Vervelde L. Recombinant Infectious Bronchitis Viruses Expressing Chimeric Spike Glycoproteins Induce Partial Protective Immunity against Homologous Challenge despite Limited Replication In Vivo. J. Virol. 2018;92:e01473-18. doi: 10.1128/JVI.01473-18. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials